Ternary Therapeutics

TernaryTx develops a computational drug discovery platform that combines machine learning and molecular dynamics to design small molecule therapeutics known as molecular glues. The platform utilizes four specialized engines—Leopard, Puffin, Gecko, and Octopus—to assess protein glueability, predict ternary complex structures, and optimize molecular affinity. The company targets the pharmaceutical industry by unlocking previously undruggable biological targets through prospective molecular design.